Becton, Dickinson and Company (BDX) analyst actions
Rating and price-target actions on BDX in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the BDX overview →
1 measured BDX analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| BD Initiates International Study to Expand Treatment Options for Patients with Peripheral Arterial Disease | Press release | +0.20% | +0.55% |
Keep exploring
More BDX: earnings → · SEC filings → · BDX overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PFENEX INC (PFNX) | 574 | 0.00% | 45% |
| VICAL (VICL) | 574 | -0.00% | 38% |
| Myriad Genetics, Inc. (MYGN) | 560 | -0.09% | 46% |
| Tilray Brands, Inc. (TLRY) | 558 | -0.32% | 41% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.